Showing results (311-320 of 405) with videos related to

Sort By:
Pageof 41
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS studyTanuja Chitnis, Brenda Banwell, Lauren Krupp, et al.
Neuroreport|August 8, 2014
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2Rohit Bakshi, Mohit Neema, Shahamat Tauhid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter studyKeren Regev, Brian C Healy, Anu Paul, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 17, 2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MSHrishikesh Lokhande, Mattia Rosso, Shahamat Tauhid, et al.
Multiple Sclerosis and Related Disorders|June 5, 2024
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumabZahra Nasr, T Charles Casper, Michael Waltz, et al.
Neurology|October 24, 2014
Protective environmental factors for neuromyelitis opticaJennifer Graves, Siri Grandhe, Kelley Weinfurtner, et al.
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Journal of Child Neurology|November 17, 2012
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States networkLaura Julian, Dana Serafin, Leigh Charvet, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Pageof 41